Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Woodford loses touch with Ultrahaptics
Woodford Investment Management has reportedly reaped $24.1m on its 20% stake in University of Bristol's Ultrahaptics.
GraphPad scribbles down SnapGene
SnapGene, a molecular biology documentation spinout of UChicago, has been acquired by scientific data analysis tool provider GraphPad Software.
Freiburg celebrates Cytena exit
Cell culturing technology Cellink has bought University of Freiburg's single-cell dispensing spinout Cytena for almost $34m.
Aquinox combines with Washington’s Neoleukin
UW-founded cancer immunotherapy developer Neoleukin Therapeutics will merge with Aquinox in an all-share deal giving the spinout's shareholders roughly 38.6% equity in the new company.
Ford receives Quantum Signal
Quantum Signal has been bought by Ford after two decades of quietly producing technologies for robotic applications including autonomous driving.
VMware vies for Uhana acquisition
Telstra Ventures looks set to exit Stanford spinout Uhana in an an acquisition of undisclosed size by VMware.
Microsoft tames BlueTalon for acquisition
Microsoft has bought big data access control software developer BlueTalon, which had raised approximately $26m from investors including Stanford-StartX Fund.
Kinectrics connects with Gnosys Global
Kinectrics has bought University of Surrey's Gnosys Global in a bid to extend its global presence and unlock the potential of a combined product portfolio.

Other News

Woodford trims Mercia stake
Woodford Investment Management has reduced its holding in Mercia Asset Management amid reports its Patient Capital Trust could move to replace Neil Woodford as manager.
TikTok swings by to collect Jukedeck
University of Cambridge's automated music production app developer Jukedeck has been picked up by internet technology firm Bytedance's TikTok.
Daily deal net: July 18, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Woodford prepares biotech clearance
Woodford Investment Management will auction unlisted biotech investments which include Oxford Nanopore in a process that could take three months to reach its conclusion.
Amal advances to $365m acquisition
Boehringer Ingelheim will pay a total of up to $365m to acquire its venture fund's portfolio company Amal Therapeutics, an immunotherapy spinout of University of Geneva.
Roche’s Spark acquisition hits delay
The deadline for Roche’s $4.3bn purchase of CHOP's gene therapy developer Spark has been postponed until April 2020 amid regulatory scrutiny and pending lawsuits.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Nucana and Nightstar race to public markets
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
test reg